BIOTRONIK Home Monitoring benefits heart patients without increasing costs
Results from the BIOTRONIK-sponsored European Health Economic Trial on Home Monitoring in ICD Therapy (EuroEco) found that providers had no additional costs, and payers even experienced a trend towards cost reduction when using BIOTRONIK Home Monitoring® versus conventional in-office follow-up. September 01, 2014